We recognize that climate change is a critical global challenge, and we have a long-standing commitment to reducing our carbon footprint. This section presents together our position on climate change, our transition plan toward zero emissions, and our latest CDP corporate disclosure. CDP (Carbon Disclosure Project) is a global system for environmental reporting.

We acknowledge the growing global pressure on water resources and our responsibility to use and discharge water responsibly. This section outlines Lundbeck’s position on water, including our approach to usage, wastewater management, and related environmental risks.

We recognize that materials use, waste, and emissions contribute to our overall environmental impact. Our position describes how we work to reduce resource consumption and promote circular practices.

We acknowledge the importance of protecting ecosystems and species affected by human activity. Our position describes how Lundbeck addresses biodiversity in our operations and research practices.

Staying healthy and safe at work is a fundamental right at Lundbeck. Our health, safety and wellbeing documents describe how we work to continuously improve physical health, mental wellbeing, and workplace safety.

We are committed to respecting internationally recognized human rights in our business and supply chain. Our human rights documents describe how we work to identify, prevent, and mitigate risks, and how we report transparently in line with legal requirements. This includes our annual disclosure under the UK Modern Slavery Act and our reporting under Canadian legislation on forced and child labour in supply chains.

Ensuring access to brain health treatments is an important part of Lundbeck’s responsibility as a pharmaceutical company. This section contains our positions, commitments, and partnerships that describe how we work to improve availability and affordability of medicines, including responsible pricing practices.

We are committed to fostering an inclusive and equitable workplace where every colleague is treated with respect and given the opportunity to contribute meaningfully. Embracing diversity of background, experience, and perspective strengthens our decision-making, fuels innovation, and supports our ability to deliver on our purpose of improving brain health.

Our global ID&E Policy provides the foundation for how we promote inclusion, prevent discrimination, and uphold fair and responsible business conduct across our worldwide operations and the many communities we serve.

Product safety and quality are fundamental priorities for Lundbeck. The Quality Policy ensures that medicines are manufactured and distributed in compliance with global regulations and Good Practice (GxP) standards. It emphasizes building quality into every stage of development, fostering a strong quality culture, and making employees accountable.

Patient’s safety is safeguarded through our global Pharmacovigilance System, overseen by the Global Patient Safety department. This system ensures continuous monitoring of benefit-risk profiles of Lundbeck products on the market and in development, evaluation of safety data from all sources incl. reporting of adverse events from patients and healthcare professionals, and compliance with international pharmacovigilance requirements. Together, these activities protect patients, ensure regulatory compliance, and reinforce our commitment to safe and effective treatments.

Read more here.

These guiding documents are internal and not publicly available, but they are central to protecting patients, supporting regulatory compliance, and ensuring safe and effective treatments.
 

Lundbeck’s Code of Ethics is the backbone of our ethics and compliance culture. It expresses the ethical principles and standards expected of all employees and external partners working on our behalf, ensuring alignment with internal and external requirements.

Responsible business conduct at Lundbeck is about ensuring that we meet our ethical and legal obligations in all parts of our value chain. This includes having robust global due diligence processes to identify and address risks and clear requirements for external partners working on our behalf.

At Lundbeck, ensuring animal welfare is our priority. Only when no alternative exists and when the benefits outweigh the possible risks of discomfort for the animals, do we conduct studies on animals. Lundbeck is obliged by the authorities to conduct studies on animals to advance safe and efficacious medicines to treat brain diseases. We provide appropriate care for our animals and continuously work to improve our animal research policy, procedures, and animal facilities. Our expectations related to animal welfare practices in our own facilities, in whatever country, and by external partners worldwide, when using living animals to conduct studies on our behalf, are stated in the Marseille Declaration.

Lundbeck acts with respect and integrity in everything we do, including observing applicable laws, regulations, guidelines and industry standards. Lundbeck’s Tax Policy sets forward the principles by which we manage our tax affairs in a compliant and accountable manner and includes our country-by-country reporting.

Lundbeck is committed to safeguarding personal data in compliance with applicable laws and to using data responsibly in research, business, and operations. Our Data Ethics Policy sets the principles for ethical use of all data, while our privacy governance framework reinforces accountability and high standards for the protection and processing of personal data.